AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

NewMed Energy

Regulatory Filings Nov 9, 2022

7125_rns_2022-11-09_d7d19b70-7de2-41be-bbf5-314c622cf28a.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8094F

NewMed Energy

09 November 2022

Joint Press Release

November 9, 2022

NewMed Energy and Uniper sign a non-binding MoU to explore collaboration options for the delivery of natural gas to Europe and the development of blue hydrogen

·      In view of the natural gas crisis in Europe, the companies are looking to enter into short and long-term cooperation agreements to bring LNG from Israel to Europe

·      In accordance with NewMed Energy's strategic plan for the development of alternative energies, the parties will examine cooperation in the field of blue and green hydrogen

§ Yossi Abu, CEO of NewMed Energy: "Natural gas will be the most significant energy source in the world for the foreseeable future."

§ Niek den Hollander, CCO of Uniper: "This collaboration with NewMed Energy fits our strategy of diversifying our gas supply sources and paving the way to a decarbonized world."

NewMed Energy and Uniper have signed a non-binding MoU to explore ways of collaborating on the supply of LNG in the short and long term and producing blue and green hydrogen.

According to the MoU, the parties will look into the supply of natural gas from Israel to Germany in the immediate term using existing production and transmission infrastructure in line with the availability of the transmission pipeline between Israel and Egypt, where the natural gas will be delivered to LNG facilities, and from there to Germany.

In addition, according to the MoU, the two sides will investigate the feasibility of LNG deliveries from the Leviathan reservoir to Uniper, which will require expansion of the existing Leviathan infrastructure (Phase 1B) as well as liquefaction of the gas at one of the existing facilities in Egypt or at a new-build independent floating liquefaction facility in Israel.

In line with NewMed Energy's strategic plan according to which the partnership is aimed at promoting green energy, the MoU also includes potential collaboration in the field of blue hydrogen and green hydrogen and its transportation from Israel to Europe.

Yossi Abu, CEO of NewMed Energy: "For the foreseeable future, natural gas will be the most significant energy source in the world. NewMed Energy is continuing to promote its international activity. Leviathan is an energy anchor in the Middle East, supplying energy to Israel and other countries in the region, while also being able to help in the energy crisis in Europe."

Niek den Hollander, CCO of Uniper: "This collaboration with NewMed Energy fits our strategy of diversifying our gas supply sources and paving the way to a decarbonized world. Sourcing natural gas from offshore Israel has the potential to increase security of supply for Germany."

For more information, please contact:

NewMed Energy - UK media

Billy Clegg / Owen Roberts / Violet Wilson

T 0203 781 8338

[email protected]

NewMed Energy - Israel / International media

Adar Hershkovitz

Spokesperson of NewMed Energy

T + 972 54 7917 156

[email protected]

Uniper SE

Dr. Adrian Schaffranietz

Coordinator Hydrogen Communications and Governmental Relations

T + 49 (0) 151 120 303 24

[email protected]

About NewMed Energy

The largest, longest standing and most experienced energy body in Israel. In the last twenty-five years, the partnership has acquired a global reputation in the fields of natural gas exploration and production, while being at the center of the discovery of all of the natural gas fields in Israel (Tamar 2009, Leviathan 2010, Tanin 2011, Karish 2013, and more), and recording exceptional success rates relative to the industry standard, and was a key partner in the development and production of natural gas from the Yam Tethys, Tamar and Leviathan projects. The extensive ties that NewMed Energy has made in the region are what have facilitated the reaching of unprecedented agreements, in the context of which the gas reservoirs in Israel export significant quantities of natural gas to customers in Jordan and Egypt. NewMed Energy holds 45% of the Leviathan reservoir and 30% of the Aphrodite gas field.

About Uniper

Uniper is a leading international energy company, has around 11,500 employees, and operates in more than 40 countries. The company plans for its power generation business in Europe to be carbon-neutral by 2035. Uniper's roughly 33 GW of installed generation capacity make it one of the world's largest electricity producers. The company's core activities include power generation in Europe, global energy trading and a broad gas portfolio, which makes Uniper one of Europe's leading gas companies. In addition, Uniper is a reliable partner for communities, municipal utilities, and industrial enterprises for planning and implementing innovative, lower-carbon solutions on their decarbonization journey. Uniper is a hydrogen pioneer, is active worldwide along the entire hydrogen value chain, and is conducting projects to make hydrogen a mainstay of the energy supply

This press release may contain forward-looking statements based on current assumptions and forecasts made by Uniper SE Management and other information currently available to Uniper. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. Uniper SE does not intend, and does not assume any liability whatsoever, to update these forward-looking statements or to modify them to conform with future events or developments.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAEAPFNEEFAFEA

Talk to a Data Expert

Have a question? We'll get back to you promptly.